Immunoexpression of transforming growth factor beta in desmoplastic ameloblastoma

Virchows Arch. 2000 Apr;436(4):319-23. doi: 10.1007/s004280050453.

Abstract

Desmoplastic ameloblastoma (DA) is an unusual subtype of ameloblastoma histologically characterized by the pronounced collagenized stroma. In the present study, the immunolocalization of transforming growth factor beta (TGF-beta), one of the most potent local factors for modulating extracellular matrix formation, was observed in DA in order to study its participation in the stromal desmoplasia. Seven cases of DA, including a "hybrid" lesion, were studied together with ten cases of ordinary follicular and plexiform ameloblastomas as the control. In contrast to ordinary ameloblastomas, marked immunoexpression was observed in all DAs but one. In the "hybrid" lesion, TGF-beta was not expressed in the area of follicular ameloblastoma but in that of DA. These results show that TGF-beta produced by tumor cells of DA plays a part in the desmoplastic matrix formation.

MeSH terms

  • Adolescent
  • Adult
  • Ameloblastoma / metabolism*
  • Ameloblastoma / pathology
  • Collagen / metabolism
  • Female
  • Humans
  • Immunohistochemistry
  • Jaw Neoplasms / metabolism*
  • Jaw Neoplasms / pathology
  • Male
  • Middle Aged
  • Transforming Growth Factor beta / metabolism*

Substances

  • Transforming Growth Factor beta
  • Collagen